We are live on
!
Find out more
GG
Gofen & Glossberg Portfolio holdings
AUM
$3.89B
1-Year Est. Return
11.97%
This Fund
S&P 500
This Quarter
Est. Return
+7.35%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$306M
(+7.8%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
591
New
35
Increased
212
Reduced
160
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$7.31M |
| 2 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$2.91M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$2.83M |
| 4 |
Constellation Brands
STZ
|
+$2.77M |
| 5 |
Air Products & Chemicals
APD
|
+$2.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$2.35M |
| 2 |
Cambria Tail Risk ETF
TAIL
|
+$2.23M |
| 3 |
Apple
AAPL
|
+$1.67M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.64M |
| 5 |
Microsoft
MSFT
|
+$1.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.06% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 12.73% |
| 4 | Communication Services | 9.04% |
| 5 | Consumer Staples | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
426
DELISTED
QVC Group Inc Series A
QVCGA
| $182K | ﹤0.01% |
278
| – | – |
|
427
Viatris
VTRS
$20.7B
| $176K | ﹤0.01% |
12,302
-1,847
| -13% | -$26.7K |
|
|
PBPB
428
DELISTED
Potbelly
PBPB
| $158K | ﹤0.01% |
20,000
| – | – |
|
|
NYMX
429
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $40K | ﹤0.01% |
25,000
| – | – |
|
430
Denison Mines
DNN
$2.64B
| $24K | ﹤0.01% |
20,000
| – | – |
|
|
NWBO
431
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $19K | ﹤0.01% |
12,740
| – | – |
|
432
iShares MBS ETF
MBB
$39.1B
| – | – |
-2,416
| Closed | -$262K |
|
433
Trustmark
TRMK
$2.77B
| – | – |
-6,000
| Closed | -$202K |
|
|
DISCK
434
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| – | – |
-5,516
| Closed | -$203K |
|
|
CUB
435
DELISTED
Cubic Corporation
CUB
| – | – |
-3,436
| Closed | -$256K |
|
|
GWPH
436
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-1,685
| Closed | -$365K |
|
Similar funds
AIM
AAM
ZCA
GJIC
SBL
RCAMU
TFS
S
Gofen & Glossberg's Q2 2021 Portfolio in Review
As of Q2 2021, Gofen & Glossberg held 591 positions worth $4.21B, up 7.8% from $3.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Gofen & Glossberg's Q2 2021 filing shows 35 new, 212 increased, 160 reduced and 13 closed positions. Its largest new stake was Organon & Co: 22,808 shares worth $690K. The largest sale was ASML, an estimated $2.35M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Gofen & Glossberg's largest Q2 2021 buy was Organon & Co: 22,808 shares worth $690K.
- Gofen & Glossberg added most to Alcon in Q2 2021, an estimated $7.31M increase.
- Gofen & Glossberg's biggest Q2 2021 reduction was ASML, cutting an estimated $2.35M.
- Gofen & Glossberg fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $365K.
- Gofen & Glossberg's ten largest holdings make up 29% of its $4.21B portfolio in Q2 2021.
- Gofen & Glossberg opened 35 new positions and closed 13 in Q2 2021.
- Gofen & Glossberg's portfolio value rose 7.8% quarter-over-quarter to $4.21B.
Based on Gofen & Glossberg's 13F filing for Q2 2021, filed 13 Jul 2021.